Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France

The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food animals, it was most likely introduced into F...

Full description

Bibliographic Details
Main Authors: Svetlana Egorova, Mohammed Timinouni, Marie Demartin, Sophie A. Granier, Jean M. Whichard, Vartul Sangal, Laëtitia Fabre, Aurélia Delauné, Maria Pardos, Yves Millemann, Emmanuelle Espié, Mark Achtman, Patrick A.D. Grimont, François-Xavier Weill
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2008-06-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/14/6/07-1168_article
id doaj-533962b685b643dcae91ee2b111ac6ac
record_format Article
spelling doaj-533962b685b643dcae91ee2b111ac6ac2020-11-25T00:38:19ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592008-06-0114695495710.3201/eid1406.071168Ceftriaxone-Resistant Salmonella enterica Serotype Newport, FranceSvetlana EgorovaMohammed TiminouniMarie DemartinSophie A. GranierJean M. WhichardVartul SangalLaëtitia FabreAurélia DelaunéMaria PardosYves MillemannEmmanuelle EspiéMark AchtmanPatrick A.D. GrimontFrançois-Xavier WeillThe multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.https://wwwnc.cdc.gov/eid/article/14/6/07-1168_articleSalmonella entericamultidrug resistanceceftriaxoneserotype NewportCMY-2France
collection DOAJ
language English
format Article
sources DOAJ
author Svetlana Egorova
Mohammed Timinouni
Marie Demartin
Sophie A. Granier
Jean M. Whichard
Vartul Sangal
Laëtitia Fabre
Aurélia Delauné
Maria Pardos
Yves Millemann
Emmanuelle Espié
Mark Achtman
Patrick A.D. Grimont
François-Xavier Weill
spellingShingle Svetlana Egorova
Mohammed Timinouni
Marie Demartin
Sophie A. Granier
Jean M. Whichard
Vartul Sangal
Laëtitia Fabre
Aurélia Delauné
Maria Pardos
Yves Millemann
Emmanuelle Espié
Mark Achtman
Patrick A.D. Grimont
François-Xavier Weill
Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France
Emerging Infectious Diseases
Salmonella enterica
multidrug resistance
ceftriaxone
serotype Newport
CMY-2
France
author_facet Svetlana Egorova
Mohammed Timinouni
Marie Demartin
Sophie A. Granier
Jean M. Whichard
Vartul Sangal
Laëtitia Fabre
Aurélia Delauné
Maria Pardos
Yves Millemann
Emmanuelle Espié
Mark Achtman
Patrick A.D. Grimont
François-Xavier Weill
author_sort Svetlana Egorova
title Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France
title_short Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France
title_full Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France
title_fullStr Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France
title_full_unstemmed Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France
title_sort ceftriaxone-resistant salmonella enterica serotype newport, france
publisher Centers for Disease Control and Prevention
series Emerging Infectious Diseases
issn 1080-6040
1080-6059
publishDate 2008-06-01
description The multidrug-resistant (MDR) Salmonella enterica serotype Newport strain that produces CMY-2 β-lactamase (Newport MDR-AmpC) was the source of sporadic cases and outbreaks in humans in France during 2000–2005. Because this strain was not detected in food animals, it was most likely introduced into France through imported food products.
topic Salmonella enterica
multidrug resistance
ceftriaxone
serotype Newport
CMY-2
France
url https://wwwnc.cdc.gov/eid/article/14/6/07-1168_article
work_keys_str_mv AT svetlanaegorova ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT mohammedtiminouni ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT mariedemartin ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT sophieagranier ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT jeanmwhichard ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT vartulsangal ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT laetitiafabre ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT aureliadelaune ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT mariapardos ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT yvesmillemann ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT emmanuelleespie ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT markachtman ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT patrickadgrimont ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
AT francoisxavierweill ceftriaxoneresistantsalmonellaentericaserotypenewportfrance
_version_ 1725297840518856704